Mesoblast Stock Market Value
| MEOBF Stock | USD 1.90 0.55 40.74% |
| Symbol | Mesoblast |
Mesoblast 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mesoblast's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mesoblast.
| 06/28/2025 |
| 12/25/2025 |
If you would invest 0.00 in Mesoblast on June 28, 2025 and sell it all today you would earn a total of 0.00 from holding Mesoblast or generate 0.0% return on investment in Mesoblast over 180 days. Mesoblast is related to or competes with Oxford Nanopore, Neuren Pharmaceuticals, Genus Plc, PeptiDream, CStone Pharmaceuticals, Pharma Mar, and Zur Rose. Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapor... More
Mesoblast Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mesoblast's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mesoblast upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0659 | |||
| Maximum Drawdown | 48.73 | |||
| Potential Upside | 11.58 |
Mesoblast Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mesoblast's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mesoblast's standard deviation. In reality, there are many statistical measures that can use Mesoblast historical prices to predict the future Mesoblast's volatility.| Risk Adjusted Performance | 0.0622 | |||
| Jensen Alpha | 0.6453 | |||
| Total Risk Alpha | (0.22) | |||
| Treynor Ratio | (2.27) |
Mesoblast Backtested Returns
Mesoblast appears to be extremely dangerous, given 3 months investment horizon. Mesoblast has Sharpe Ratio of 0.0754, which conveys that the firm had a 0.0754 % return per unit of risk over the last 3 months. By analyzing Mesoblast's technical indicators, you can evaluate if the expected return of 0.64% is justified by implied risk. Please exercise Mesoblast's Risk Adjusted Performance of 0.0622, mean deviation of 3.13, and Standard Deviation of 8.43 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Mesoblast holds a performance score of 5. The company secures a Beta (Market Risk) of -0.28, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Mesoblast are expected to decrease at a much lower rate. During the bear market, Mesoblast is likely to outperform the market. Please check Mesoblast's kurtosis, as well as the relationship between the day median price and period momentum indicator , to make a quick decision on whether Mesoblast's current price movements will revert.
Auto-correlation | -0.47 |
Modest reverse predictability
Mesoblast has modest reverse predictability. Overlapping area represents the amount of predictability between Mesoblast time series from 28th of June 2025 to 26th of September 2025 and 26th of September 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mesoblast price movement. The serial correlation of -0.47 indicates that about 47.0% of current Mesoblast price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Mesoblast lagged returns against current returns
Autocorrelation, which is Mesoblast pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mesoblast's pink sheet expected returns. We can calculate the autocorrelation of Mesoblast returns to help us make a trade decision. For example, suppose you find that Mesoblast has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mesoblast regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mesoblast pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mesoblast pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mesoblast pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Mesoblast Lagged Returns
When evaluating Mesoblast's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mesoblast pink sheet have on its future price. Mesoblast autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mesoblast autocorrelation shows the relationship between Mesoblast pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Mesoblast.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Additional Information and Resources on Investing in Mesoblast Pink Sheet
When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:Check out Mesoblast Correlation, Mesoblast Volatility and Mesoblast Alpha and Beta module to complement your research on Mesoblast. For more detail on how to invest in Mesoblast Pink Sheet please use our How to Invest in Mesoblast guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Mesoblast technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.